ExploreInsights

Shefali Agarwal

Scientific Advisor

Dr. Shefali Agarwal is Epizyme’s Chief Medical Officer where she led the approval of Tazverik for Relapsed/Refractory Follicular Lymphoma and Epithelioid Sarcoma. She is currently also serving as a Board of Director for FATE Therapeutics and ITB-Med. Prior to joining the Epizyme, Shefali held leadership positions across medical research, clinica...

Roles at Imvax

  • Scientific Advisor

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.